Bryan C. Cressey - 26 May 2021 Form 4 Insider Report for SELECT MEDICAL HOLDINGS CORP (SEM)

Role: Director
Signature: /s/ Michael E. Tarvin, as attorney-in-fact
Issuer symbol: SEM
Transactions as of: 26 May 2021
Net transactions value: -$401,100
Form type: 4
Filing time: 28 May 2021, 16:05:13 UTC
Previous filing: 26 May 2021
Next filing: 16 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SEM	Common Stock	Sale	$401,100	-10,000	-11%	$40.11	80,000	26 May 2021	By the Bryan Cressey and Iliana Sweis Cressey Foundation	F1, F2
holding	SEM	Common Stock						53,799	26 May 2021	Direct
holding	SEM	Common Stock						383,850	26 May 2021	By Cressey Investments LLC	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.33, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	The reporting person beneficially owns the shares indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.33, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reporting person beneficially owns the shares indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.